Clinical Trial Update: Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

View source ↗

Summary

This clinical trial evaluates a lung cancer screening program in a public service setting that combines low-dose tomography with metabolomic evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Lung Cancer | Status: RECRUITING